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Abstract
Three-dimensional (3D) cell models that mimic the structure and function of native tissues are enabling more detailed study of
physiological and pathological mechanisms in vitro. We have previously demonstrated the ability to build and manipulate 3D
multicellular microscopic structures using holographic optical tweezers (HOTs). Here, we show the construction of a precisely
patterned 3D microenvironment and biochemical gradient model consisting of mouse embryoid bodies (mEBs) and polymer
microparticles loaded with retinoic acid (RA), embedded in a hydrogel. We demonstrate discrete, zonal expression of the RA-
inducible protein Stra8 within mEBs in response to release of RA from polymer microparticles, corresponding directly to the
defined 3D positioning of the microparticles using HOTs. These results demonstrate the ability of this technology to create
chemical microgradients at definable length scales and to elicit, with fidelity and precision, specific biological responses. This
technique can be used in the study of in vitro microenvironments to enable new insights on 3D cell models, their cellular
assembly, and the delivery of drug or biochemical molecules for engineering and interrogation of functional and morphogenic
responses.
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Introduction
Our ability to understand the complex biology and physiology
of cells and tissues is being advanced through innovative ap-
proaches to reproduce their multicellular three-dimensional
(3D) interactions, structure, and function in vitro. With the
relatively simple approach of culturing different cell types,
together with specific signaling factors and natural or synthet-
ic scaffolds, cells can be encouraged to self-assemble and
form organized 3D cellular structures in vitro that mimic na-
tive tissues. Organoids and organ-on-chip technologies are
now enabling investigation of specific developmental,
physiological, and disease processes and to dissect the effects
and mechanisms of biochemical factors or drugmolecules in a
controlled manner [1–8].
The level of precision and accuracy of control of cell inter-
actions and delivery of bio-instructive signals that can be
achieved is varied among these technologies, and the ability
to work interactively and precisely at the scale of individual
cells and their microenvironment is a particular challenge [9].
Meeting this challenge, we have established the use of holo-
graphic optical tweezers to enable simultaneous imaging and
micromanipulation of multiple cells, as well polymer micro-
particles within 3D culture environments [10]. These can be
precisely positioned and assembled, within a matter of
minutes, into predetermined 3D microtissue structures,
with accuracy of control from micron- to millimeter-
length scales (10).
In this study, we use HOTs to create biochemical gradients
within 3D microenvironments by precise positioning of mi-
croparticles loaded with a biochemical factor and induction of
highly localized responses in mouse embryoid bodies (EBs).
The formation of EBs from embryonic stem (ES) cells has
been used extensively as a model to investigate in vitro differ-
entiation of particular cell types in response to specific
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biochemical factors [11–15]. Various approaches have been
used to stimulate differentiation, including simply adding bio-
chemical factors to the culture medium [11–13] through to
aggregating ES cells together with microparticles doped with
biochemical factors [14, 15]. While such studies demonstrate
directed and localized differentiation of ES cells and EBs in
response to bio-instructive signals, the results are often highly
variable, with minimal predictable and repeatable targeted
control of differentiation within defined cell populations or
locations within the 3D cellular aggregates.
To demonstrate the potential of HOTs to achieve precision
delivery of bio-instructive signals with concomitant biological
responses at defined locations within EBs we have used a
robust and highly sensitive retinoic acid (RA) inducible ge-
netic system. Recent work has shown that mES cells are sen-
sitive to low concentrations of RA resulting in marked in-
creases of two RA responsive elements (RAREs), stimulated
by RA gene 8 (Stra8) and deleted in azoospermia-like (Dazl)
[16, 17]. The expression of these two RAREs is tightly linked
to RA concentration and up to 800-fold increases have been
reported after just 24 h of exposure [16, 17]. This presents a
robust model to demonstrate highly localized release of RA
and expression of Stra8.
In this study, we show the formulation of RA encapsulated
microparticles with controlled release profiles, together with
an approach to enable selection of microparticles with high
RA loading efficiency. Subsequently, we show the precise
positioning of small numbers of RA encapsulated microparti-
cles to defined X, Y, Z locations and distances around mEBs
and the resulting highly localized induced expression of Stra8,
correlating directly with the positioning of RA release source.
Lay Summary (98/100)
Advances in growing cells in a culture dish and forming
organized 3D cellular structures that mimic tissues in our
body are greatly improving the study of biological pro-
cesses in health and disease. Using an instrument called
holographic optical tweezers, we have shown how a non-
damaging light source can literally work as a pair of mi-
croscopic tweezers. We demonstrate the ability to interac-
tively and precisely build microscopic tissues and to de-
liver biochemical or drug molecules and induce highly
localized responses in the cells. This technology has great
potential for building accurate tissue models to test and
develop new drugs.
Future Work (50/50)
To build more complex 3D models of biochemical gradi-
ents, including localized delivery of single or multiple
factors and dynamic monitoring of localized release kinet-
ics and cell responses. Recent studies on spontaneous
in vitro assembly of embryo-like structures present a ro-
bust model to build localized biochemical gradients and
interrogate developmental processes.
Methods
Holographic Optical Tweezer (HOT) Systems
Experiments were performed with the HOTs instrument as
described previously [10] and a commercially available por-
table system (CUBE; Meadowlark Optics, USA). Both sys-
tems are based on an infra-red laser for bio-applications. All
software-based control functions were programmed using
LabVIEW software (National Instruments) as described pre-
viously [10]. The CUBE system was housed in a standard cell
culture incubator (37 °C, 5% CO2) facilitating HOTs con-
trolled patterning of cells and microparticles under standard
culture conditions.
Mouse Embryonic Stem (mES) Cell Culture
The mES cell line (denoted CGR8) [18] was cultured on 0.1%
(v/v) gelatin solution. Medium consisted of Dulbecco’s mod-
ified Eagle’s medium (DMEM) (Life Technologies) supple-
mented with 10% (v/v) fetal bovine serum (FBS) (Sigma-
Aldrich), 2 mM L-glutamine (Life Technologies), 0.1 μM 2-
mercaptoethanol (Sigma-Aldrich), 50 μg/mL penicillin/strep-
tomycin (Life Technologies), and 5000 U/mL leukemia inhib-
itory factor (LIF) (Calbiochem).
Formation of Embryoid Bodies (mEBs) by Hanging
Drop
Prior to aggregation, mES cells were transiently serum
started by culturing in mES cell culture medium without
FCS for 24 h to minimize any RA-induced responses be-
fore the controlled release experiments. Uniformly sized
cell aggregates, mES cells were created by the hanging
drop method [13]. Cell suspensions were diluted to 2 ×
104 cells/mL in the same medium as above without LIF
and then, using a multi-flow pipette (8 tips), 25-μL vol-
umes were deposited onto the underside of a 60 mm Petri
dish lid to form eight rows. The resulting 64 droplets
containing mES cells were then inverted and the lid is
placed on the Petri dish containing PBS. The droplets
containing roughly 500 cells were cultured for 24 h and
the resulting cell aggregates were collected and suspended
in a pre-gel GelMA solution ready for patterning on the
HOTS system.
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Immunohistochemical Staining of Stra8 in mES Cells
and mEBs
Dose–response effects of RA on expression of Stra8 were
initially assessed by adding RA directly to culture medium
and culturing ES cells or EBs in concentrations of RA at 0,
10, 100, and 1000 nM for 24 h. Subsequently, the experiments
were repeated with solutions of RA released from microparti-
cles allowing comparison of freshly prepared RA. ES cells
and EBs were fixed in 3.5% paraformaldehyde for 20 min.
Fixed cell samples were permeabilized in 0.1% (w/v) Triton
X-100 (diluted in PBS) for 40min at room temperature for cell
monolayers and 90 min for cell aggregates. Following perme-
abilization, samples were covered in blocking solution for
30 min at room temperature. Aggregates were immunostained
by incubation overnight at 4 °C with rabbit anti-Stra8 primary
(Abcam) diluted 1:100. After washing 3 × 10 min with PBS,
the aggregates were incubated for 2 h at room temperature
with anti-rabbit Alexa Fluor 546 fluorescent secondary anti-
body (Invitrogen) diluted 1:200. Immunostaining was visual-
ized by conventional fluorescence and confocal microscopy.
In all experiments, qualitative observations are presented and
described and for each individual experiment images were
collected at similar exposure settings.
Retinoic Acid (RA) Microparticle Encapsulation
Retinoic acid containing PLGA/TBIIF (70:30) polymer mi-
croparticles with an average size of 5 μmwere produced using
a single-emulsion, water-in-oil encapsulation method as pre-
viously described [19]. Briefly, 2 mg RA was solubilized in
dichloromethane (DCM) along with 700 mg PLGA and
300 mg TBIIF, 10 mg FITC-BSA (or 10 mg unlabeled
BSA), and 200 mL of 0.3% (w/v) poly vinyl alcohol and
[atRA] Hoechst
Anti-Stra8
AlexaFlour488
1000nM
100nM
10nM
0nM
Fig. 1 Dose–response effects of
RA on Stra8 expression in mES
cells. Stra8
immunocytochemistry staining
showing the response of mES
cells to a range (0–1000 nM) of
RA concentrations. Cells were
counterstained with Hoechst dye.
Scale bar represents 100 μm.
atRA, all trans retinoic acid
Regen. Eng. Transl. Med.
homogenized at 4000 rpm for 2 min. The solution was stirred
at 300 rpm for 4 h to allow the DCM to evaporate. The
resulting microparticles were then collected by centrifugation,
the particles were washed with distilled water three times and
snap frozen in liquid nitrogen and freeze dried (Edwards
Modulyo D, IMA Edwards, UK) for 2 days.
Encapsulation Efficiency of Microparticles
Using an adapted version of the method published by Sah
(1997) [20], 15 mg of loaded PLGA microparticles was dis-
solved in 750 μL of DMSO and 2150 μL of 0.02% (w/v) SDS
in 0.2 M NaOH for 1 h at room temperature and 150-μL
aliquots of each solution were added to a well plate and a
bicinchoninic acid (BCA) assay (Sigma-Aldrich) was per-
formed. Appropriate standards of BSAwere created, and after
2 h of incubation at 37 °C, the plate was scanned at 562 nm on
a plate reader. The total protein content was then calculated via
a polynomial equation of the standard curve, and the encap-
sulation efficiency was calculated from the theoretical expect-
ed loading of the microparticles. The microparticle batches
were lyophilized and the powder was vacuum packed and
stored at 4 °C until required. The size distribution of micro-
particle batches was determined by suspension in deionized
water (20 mg/mL) and sized using a laser diffraction method
(Coulter LS230; Beckman Coulter, UK).
For release kinetics, 25 mg of microparticles was
suspended in 1.5 mL of PBS in glass tubes and then placed
on a GyroTwister and gently rocked at 5 rpm at 37 °C. At
24-h intervals, the tubes were centrifuged at 3000 rpm for
3 min. The supernatant was then carefully removed and
stored at – 20 °C for analysis. The microparticles were
then re-suspended in 1.5 mL PBS and returned to the
incubator; this process was repeated over 12 days to en-
sure complete release from the microparticles.
Fluorescence-Associated Cell Sorting (FACs) or RA
Microparticles
Microparticles containing FITC-BSA RA or BSA RA and
5-μm reference beads were suspended in PBS (25 mg/mL)
and sonicated for 30 s to break up aggregates before being
added to separate 5 mL FACS tubes under sterile conditions.
Sorting and analysis were performed using a MoFlo Astrios
Cell Sorter (Beckman Coulter, UK) equipped with a 488-nm
laser at 100 mW of power. Forward scatter (FSC1) and side
scatter (SSC) were collected through a filter and the FITC
signal was collected in the FL1 channel through a 513/26
bandpass filter. A light scatter gate was drawn in the SSC
versus FSC1 plot to include microparticles of a similar size
to 5-μm reference beads. Cells within the gate were displayed
within a SSC versus 488,513/26 intensity plot allowing a vi-
sualization of the fluorescence intensity distribution within the
microparticle batches. A final selection gating was applied to
sort based on fluorescence intensity. Microparticles were
sorted over several sessions in separate batches to reduce the
time spent suspended in PBS and were freeze dried for long-
term storage.
HOTs Patterning Procedures with Embryoid Bodies
and Microparticles
The movement and positioning of cells and microparticles
was as described previously [10]. Briefly, the system uses a
Nd:YAG, solid state, infrared (1064 nm), 3 W maximum out-
put, continuous wave, class 4 3.2-mm-beam-diameter laser
[atRA] Hoechst
Anti-Stra8
AlexaFlour488
10nM
0nM
Fig. 2 Induced expression of
Stra8 by RA in mEBs. Stra8
immunostaining in mEBs in
response to RA (10 nM), with
Hoechst counterstaining. Scale
bar represents 100 μm. atRA, all
trans retinoic acid
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adapted for biological applications (Laser Quantum). Optical
manipulation with multiple optical traps is achieved by
expanding the laser beam so that it overfills the aperture of
the spatial light modulator (SLM) chip (512 × 512 pixel fer-
roelectric liquid crystal (FLC) array) (Laser 2000). This is then
coupled with the optical tweezer system by imaging the SLM
onto the back aperture of a high numerical aperture oil immer-
sion microscope objective lens (40 × 1.3 NA Zeiss, Plan-
NeoFluar). The resulting traps can then be focused anywhere
within the field of view, with controlled holograms generated
by the SLM giving full axial and lateral control over the trap-
ping beam. All software-based control functions were pro-
grammed using LabVIEW software (National Instruments)
as described previously [10]. A patterning, microfluidic-type
gasket with multiple wells connected by channels was made
(see supplementary material). This enabled EBs and micro-
particles, together with pre-GelMA solution, to be added to
the wells and then moved and assembled by user-specified
design with the HOTs. The GelMAwas prepared as described
previously [10] and then dissolved in 80 °C photo-initiator
(Irgacure 2959 0.5% (w/v)) to yield a 10% (w/v) GelMA
solution, and stored in the dark at 4 °C until use. This
solution was warmed to 37 °C and then added to the
patterning gasket to a maximum volume of 100 μL.
Cells and microparticles to be patterned were added di-
rectly to the patterning gasket as required under sterile
conditions. Once patterning was completed, the GelMA
solution was cross-linked with a 5-s burst of UV light
from a distance of 5 cm resulting in an output of 30 W/
cm2 using a UV lamp (Omnicure S2000; JentonUV, UK).
The GelMA was left for 5 min to ensure complete
crosslinking. If prolonged cell culture was required, cell
culture medium was added on top of the cross-linked
GelMA before incubation at 37 °C with 5% CO2.
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Fig. 3 Characterization of RA-laden microparticles. aMicroparticle size
distribution by differential volume Coulter analysis. b SEM micrograph
of the microparticles demonstrating their spherical, non-porous morphol-
ogy. c In vitro release study over 10 days (error bars mark cumulative
standard error of the mean, minimum of three replicates). d
Representative immunofluorescence staining of Stra8 for each condition
and bioactivity assessment comprising fresh solutions of 10 and 100 nM
RA and solutions extracted from a suspension of RA-containing micro-
particles, estimated by microparticle mass and estimated encapsulation
efficiency to contain 100 nM RA (post-encapsulation 100 nM). Scale bar
represents 100 μm
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Results
Retinoic Acid Dose Response-Induced Expression
of Stra8 in mES Cells
The dose response experiment in Fig. 1 shows induced ex-
pression of mES cells to a range of RA concentrations, from 0
to 1000 nM. The cells were serum starved for 24 h prior to
being exposed to RA for 24 h. The fluorescence staining in-
tensity gives an indication of the level Stra8 protein expression
and is seen to increase with increasing RA concentrations.
Little or no staining was seen in absence of added RA. This
contrasts with the low-level staining seen without transient
serum starvation (data not shown).
Retinoic Acid Dose Response-Induced Expression
of Stra8 in Mouse EBs
To show effective delivery and induction of Stra8 in 3D
cell aggregates, mouse EBs were exposed to either 0 or
10 nM RA for 24 h. Figure 2 shows clear staining and
expression of Stra8 in response to 10 nM RA, with
negligible staining seen in the absence of RA. Prior to
aggregation, the ES cells were serum starved for 24 h,
and this data indicates that there were no deleterious ef-
fects on EB formation or Stra8 gene expression and back-
ground Stra8 expression remains negligible.
Retinoic Acid Encapsulation and Induction of Stra8
in mES Cells
The RA microparticles (BSA-RA co-loaded) had an aver-
age size of around 5 μm (Fig. 3a), and SEM imaging
showed they had spherical, non-porous morphology
(Fig. 5b). The in vitro release study (Fig. 5c) showed an
initial burst release within the first 24 h, followed by a
more gradual release over the next 10 days. The bioactivity
assay (Fig. 3d) showed Stra8 staining in mES cells in re-
sponse to freshly prepared RA at concentrations of 10 and
100 nM and a solution collected from a suspension of RA-
containing microparticles, estimated by microparticle mass
and estimated encapsulation efficiency, to have a RA con-
centration of 100 nM. It can be seen that the solution col-
lected from RA encapsulated microparticles showed a level
6 RA laden 
microparticles
8 RA laden 
microparticles
Hoechst
Anti-Stra8
AlexaFlour488 Hoechst
Anti-Stra8
AlexaFlour488
Fig. 4 HOTs patterned RA microparticles for zonal stimulation of Stra8
in mES aggregates. a Bright-field micrographs showing the GelMA sta-
bilized 6- and 8-microparticle patterns around mES cell aggregates with a
HOTs patterning platform. b Fluorescence immunostaining for Stra8 with
Hoechst counterstaining. Representative of N = 4 experiment repeats.
Scale bars represent 50 μm
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of staining somewhere between that seen with fresh RA at
concentrations 10 and 100 nM and confirmed the ability to
deliver RA from microparticles.
Figure 4 shows an example of the results of HOTs
patterning experiments with a defined number of BSA-
RA microparticles precisely positioned around mEBs.
Immunostaining for Stra8 was only seen in approximately
only 50% of experiments (n = 4) and was likely due to
variability in loading efficiency in the microparticles. This
data is included to show the evolution of the experiment
and our work toward induction of a highly localized re-
sponse in the EBs. The 6- and 8-microparticle patterns
were arbitrarily chosen to produce an obvious, user-
defined pattern and to achieve a localized or focused de-
livery source. There were no differences in observed ef-
fects between 6- and 8-microparticle patterns and the 6-
microparticle triangular configuration was used in all sub-
sequent experiments.
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Fig. 5 Analysis and sorting of the FITC co-loaded RA microparticles.
FITC-BSA co-loaded RA microparticles were analyzed using FACS. A
FACS analysis by means of SSC vs. FSC1 to gate for appropriately sized
microparticles based on 5-μm reference beads. b The R4 gating plotted as
SSC vs. fluorescent intensity (488–513/26 nm). c Representative sorting
gating used to yield high, medium, and low fluorescent intensity micro-
particle groups
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Analysis and Sorting of the FITC Co-Loaded RA
Microparticles
In order to be able to select small numbers of RA-laden mi-
croparticles and ensure high encapsulation efficiency of the
selected microparticles, a method of co-loading FITC-BSA
and RAwas developed. Figure 5 shows analysis and selection
of FITC co-loaded RA microparticles and sorting into differ-
ent groups of microparticles with fluorescence intensity rang-
ing from “High,” “Medium,” and “Low.” The microparticles
were initially gated based on their size versus 5-μm reference
beads, assessed by forward and side scatter (Fig. 5a). As a
means of comparison, the non-fluorescent RA-laden micro-
particles were also analyzed to provide a baseline fluorescence
intensity. The use of these microparticles as a control ensured
that any RA or polymer autofluorescence would be normal-
ized from the FITC-labeled batch. When comparing these two
batches in the “Batch fluorescent intensity distribution”
(Fig. 5b), it can be seen that the FITC co-loaded microparticles
had a much greater fluorescence intensity. Three separate
groups were created to select for “High,” “Medium,” and
“Low” fluorescence microparticles, as shown in the represen-
tative plots (Fig. 5c). Then by running a high-density suspen-
sion of the FITC co-loaded batch through the FACS process,
the three separate suspensions (“High,” “Medium,” and
“Low”) and any sub-“Low” microparticles were separated.
Analysis of the FACS Selected “High” Loading
Microparticles
Figure 6 shows that FITC fluorescence correlates with
encapsulation efficiency of BSA and by extension with
RA. With increased FITC fluorescence, greater RA is es-
timated to be encapsulated within the batch. The “High”
group was estimated to have an encapsulation efficiency
of 89.5 ± 1.8 and collectively this was expected to achieve
a robust and reliable selection and delivery process for the
HOTs patterning experiments.
HOTs Patterning of FITC-BSA/RA Microparticles
Around mEBs
Figure 7a shows the release of RA from the FITC-BSA co-
loaded RAmicroparticles over 24 h. By the 24-h point, 39.5 ±
5.9% of the loaded RA was released. Figure 7b shows the
positioning of six RA-releasing microparticles in a defined
triangular pattern formed in close proximity (within 20 μm)
to mEBs and stabilized by use of GelMA cross-linking. After
24 h, immunostaining for Stra8 can be clearly seen in local-
ized regions within the EBs closely apposed with wherever
the RA release source was placed around the EBs. Through
the use of FACS sorted “High” loading RA microparticles,
experimental success was raised from 50% (n = 4 separate
experiments) to 80% (n = 5 separate experiments).
In this experiment, we focused entirely on positioning of
the microparticles at defined locations around EBs and induc-
ing highly localized responses while maintaining the same
distance that the microparticles were positioned from the
EBs at each set location. In a related study, we have investi-
gated the ability to control specific cellular responses over
defined distances using a model of chemotactic responses of
mouse osteoblasts (see supplementary material).
Discussion
In this study, we have shown that we can build 3D cell micro-
environments with defined, reproducible control and precision
delivery, with micron resolution, of a biochemical signal gra-
dient and to induce a highly localized biological response in
multicellular aggregates directly in response to the biochemi-
cal signal.
The spatial and temporal induction of Stra8 in mEBs in
response to RA [17, 18] released from microparticles posi-
tioned at discrete locations around the 3D cellular structures
has served primarily as exemplar of the HOTs technology to
precisely deliver and induce a biological response. This builds
on our previous work with HOTs on assembly of complex
microenvironments [10] to show that the technology is also
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very amenable to creating biochemical gradients. It also
shows how the HOTs technology can complement other tech-
nologies on cellular assembly, as we have shown here by
precision engineering of the microenvironment around EBs
formed by the hanging drop method [13]. We envisage that
this can be applied to organoids and organ-on-chip models
and collectively can bridge gaps with the scale of cellular
assembly, precision of cellular organization and accurate con-
trol of delivery of bio-instructive signals [1–8].
The sensitivity and relative simplicity of the RA-inducible
Stra8 model [17, 18] was extremely useful for refining the
delivery of biochemical factors from microparticles and spe-
cifically adapting their use for selecting and positioning small
numbers of microparticles. Formulation of microparticles and
the controlled release of soluble biochemical factors and drug
molecules is well established with wide-ranging, demonstrated
applications [21–28]. In many cases, controlled release studies
are performed with bulk volumes of microparticles, and while
it is known that loading within individual microparticles can
be highly variable, this is relatively unimportant unless there is
a need to work with individual microparticles. As we found in
our studies with HOTs positioning of RA microparticles, in
some experiments Stra8 expression was induced in EBs, and
in other experiments, no expression was seen, suggesting var-
iable loading of RA in the HOTs selected microparticles.
We were able to overcome this limitation by co-loading
microparticles with FITC-BSA and RA and through FACS
we were able to specifically select particles with high loading
efficiency and markedly increase the success rate in inducing
localized expression of Stra8. The burst release kinetics of the
microparticles, combined with the ability to reproducibly and
accurately position them at defined locations around the EBs,
stabilized with GelMA, facilitated highly localized RA-induced
responses in regions of the EBs directly facing the RA
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Fig. 7 Zonal delivery of retinoic acid to mEBs. a Plot of the in vitro
release study completed over 24 h for the release of retinoic acid from
retinoic acid encapsulated microparticles. Error bars represent the
cumulative standard error of the mean. b Fluorescence and confocal
imaging showing the positioning of 6 retinoic-acid-laden FITC
microparticles arranged into a triangular structure in close proximity of
the mEBs with the HOTs patterning platform and immunostaining for
Stra8 at discrete locations after 24 h. Representative of N = 5 experiment
repeats. Scale bars represent 50 μm
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microparticles. The choice of pattern of 6 microparticles,
roughly in an equilateral triangle configuration with the “base
of the triangle” facing the EBs, was an arbitrary choice intended
to clearly show that it was precisely patterned and included a
sufficient number of microparticles to achieve localized, fo-
cused release or RA toward the EBs sitting in close apposition.
As we have previously shown, the HOTs technology offers
considerable scope and flexibility to create a wide range of
defined patterns with microparticles, scaffolds, and cells [10].
Although we have not quantified the induced, localized
expression of Stra8, the response is highly defined and strik-
ing and serves to demonstrate a key objective of this study. In
related work, we have demonstrated and quantified chemotax-
is of mouse primary calvarial osteoblasts to platelet-derived
growth factor-BB (PDGF-BB), a known potent chemotactic
factor for osteoblasts. Agarose beads doped with PDGF-BB
(10 nM) and single mouse primary calvarial osteoblasts were
positioned at defined distances apart (50, 100, and 150 μm)
using HOTs and stabilized within gelMA (see supplementary
material). As expected, there was very clear movement of the
osteoblast toward the PDGF-BB-doped bead, with a trend of
decreasing distance moved with increasing distance of sepa-
ration. Over the 8-h time course of this experiment, it would
have been reasonable to expect a more marked gradation of
chemotaxis but, overall, there was no significant difference in
net positive migration relative to distance from the release
source. These observations serve to highlight the challenges
of creating and quantifying biochemical gradients and the
many variables involved, including the properties of the bio-
chemical factor, the kinetics of release, and the properties of
the environment through which the factor is distributed. What
is absolute from this study is that the HOTs technology and the
approach described here is highly amenable for precision as-
sembly of tunable, complex microenvironments with spatial
and temporal control of both cellular organization and deliv-
ery of bio-instructive signals.
In summary, we have demonstrated the creation of bio-
chemical gradients within 3D cellular microenvironments
and the precision delivery of bio-instructive signals by
interactively positioning biochemical-laden microparticles
around multicellular 3D aggregates at user-defined loca-
tions. While challenges remain, such as quantifying signal
gradients within cellular microenvironments, this robust,
highly interactive “cause-and-effect” type model is able to
accurately target and provide insights into understanding
and quantifying specific biological responses in 2D or 3D
cell models.
Conclusion
The construction and interrogation of multicellular 3Dmodels
and microenvironments and the capability to recapitulate
complex physiological and pathophysiological processes
in vitro is being advanced significantly by various innovative
techniques and technologies, yet our understanding remains
far from complete.
Using HOTs, we can assemble complex microenviron-
ments and create biochemical gradients with a level of control
from micron- to millimeter-length scales. As we have also
shown, this technology is very adaptable and can be used with
other technologies such as organoids and microfluidics.
Collectively, this shows that we can create more accurate
in vitro representations of the native tissue structures and sig-
naling interactions and to build multicellular 3D cell models
that enable more detailed in vitro investigation and interroga-
tion of physiological and pathophysiological responses.
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